高风险人群遗传检测外展效果数据表
评估三种外展方法和两种工作流程对高风险患者遗传检测参与率影响的数据集,参与率低于3%,同建筑工作流程效果更佳。

基本信息
资源简介
高风险人群遗传检测外展效果数据表
【一句话概览】
本数据集是 figshare 公开的文本数据集,收录 1 个文件、合计 458.95 KB,主题涵盖 genetic testing、high-risk population、location、outreach、participation,可用于医学自然语言处理(实体识别、信息抽取等),CC BY 4.0 许可开放获取。
【数据集背景】
本数据集源站标题为《Data Sheet 1_Evaluating the effectiveness of outreach efforts and testing workflow on genetic testing participation in a high-risk population.pdf》。配套论文《Participation in genetic screening: testing different outreach methods across a diverse hospital system based patient population》发表于 Frontiers in Genetics(2023),DOI:10.3389/fgene.2023.1272931。源站首次发布:2026-04-02。
【数据内容】
源站原始描述:IntroductionGenetic testing enables precision medicine by improving disease risk awareness, prevention, and treatment. Despite national guidelines, fewer than 20% of eligible US patients with a personal or family history of breast or ovarian cancer undergo testing, with notable disparities by race, age, and insurance. Population-scale programs and point-of-care strategies, such as risk assessments during mammography, aim to address these gaps. This study evaluates the effectiveness of three outr…
【数据结构与技术规格】
文件数 1 个,合计 458.95 KB。Data Sheet 1_Evaluating the effectiveness of outreach efforts and testing workflow on genetic testing participation in a high-risk population.pdf:application/pdf,458.95 KB。数据集 DOI:10.3389/fcacs.2026.1765262.s002。
【主题与分类】
源站学科分类:Cancer。主题标签:genetic testing、high-risk population、location、outreach、participation、routine care、workflow。
【适用方向】
文本类数据可用于医学自然语言处理,如命名实体识别、信息抽取与文本分类。
【获取与许可】
源站页面:https://frontiersin.figshare.com/articles/dataset/Data_Sheet_1_Evaluating_the_effectiveness_of_outreach_efforts_and_testing_workflow_on_genetic_testing_participation_in_a_high-risk_population_pdf/31922079
使用许可:CC BY 4.0(https://creativecommons.org/licenses/by/4.0/)。
规范引用:Dickey, Lindsay; Bryce, Emily; Rinaldi, J. B.; Emery, Kate; Childers, Kimberly; Brown, Sandra; et al. (2026). Data Sheet 1_Evaluating the effectiveness of outreach efforts and testing workflow on genetic testing participation in a high-risk population.pdf. Frontiers. Dataset
下载信息
注册下载
需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。
暂未开放公开下载
无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。
免登录有偿下载
公开数据集受托下载与技术交付服务。
提供高速下载与技术交付服务(收技术服务费,非数据销售)
暂未开放当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。
使用方式
数据集获取(Figshare)
- 源站标题:Data Sheet 1_Evaluating the effectiveness of outreach efforts and testing workflow on genetic testing participation in a high-risk population.pdf
- DOI:10.3389/fcacs.2026.1765262.s002
- 发布日期:2026-04-02
- 文件数:1 个
- 文件总体积:458.95 KB
- 源站页面:https://frontiersin.figshare.com/articles/dataset/Data_Sheet_1_Evaluating_the_effectiveness_of_outreach_efforts_and_testing_workflow_on_genetic_testing_participation_in_a_high-risk_population_pdf/31922079
命令行下载
curl -L -o "Data Sheet 1_Evaluating the effectiveness of outreach efforts and testing workflow on genetic testing participation in a high-risk population.pdf" "https://ndownloader.figshare.com/files/63395739"
文件清单
Data Sheet 1_Evaluating the effectiveness of outreach efforts and testing workflow on genetic testing participation in a high-risk population.pdf(458.95 KB)
文件总体积 458.95 KB(源站 API 实测)。
数据加载示例(图像类)
from PIL import Image
import glob, os
files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)
# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path) # 要求 子目录=类别
目录组织与标注格式以源站说明和下载后实际文件为准。
数据说明
IntroductionGenetic testing enables precision medicine by improving disease risk awareness, prevention, and treatment. Despite national guidelines, fewer than 20% of eligible US patients with a personal or family history of breast or ovarian cancer undergo testing, with notable disparities by race, age, and insurance. Population-scale programs and point-of-care strategies, such as risk assessments during mammography, aim to address these gaps. This study evaluates the effectiveness of three outreach methods and clinic workflow variations on genetic testing participation among high-risk patients.
MethodsThe study was conducted at eight Providence Health and Services clinics in California. To evaluate the effectiveness of three outreach methods on genetic testing participation, high-risk patients were randomized to receive one of three methods: mailed brochure, email, and SMS text message. The effectiveness of two workflows was assessed retrospectively, comparing genetic testing among patients who were offered testing in the same building to those who were required to go to a different building. Descriptive and regression analyses were used to examine associations between outreach and workflow and test order rates. A stratified analysis by workflow was used to further examine associations between patient characteristics and genetic testing.
ResultsA total of 7,112 patients received outreach methods, and 16,965 were included in the retrospective analysis by workflow. Overall, genetic testing following outreach was low, less than 3%, and did not differ by outreach method. The different building workflow was associated with a lower order rate than the same building workflow (IRR = 0.72, 95% CI = 0.65–0.80). The differences in order rates by patient characteristics were larger in the different building workflow.
ConclusionThe findings suggest that while outreach yields low engagement, low-cost methods such as email are feasible, and point-of-care access is critical for improving participation and equity. Health systems should prioritize same-day testing and provider capacity to expand access and reduce barriers.
许可
CC BY 4.0
引用
学术使用请引用 DOI 10.3389/fcacs.2026.1765262.s002(source: https://frontiersin.figshare.com/articles/dataset/Data_Sheet_1_Evaluating_the_effectiveness_of_outreach_efforts_and_testing_workflow_on_genetic_testing_participation_in_a_high-risk_population_pdf/31922079)。
数据缺失?
依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。
⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。




